Condition

Stereotactic Body Radiotherapy

ClinicalTrials.gov condition label

Clinical trials14

Recruiting2

Common interventions18

Lead sponsors shown12

Clinical trials

14 shown

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)NCT06825091 · 2025-02-04

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary OligometastasesNCT06542159 · 2024-05-22

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.NCT07608159 · 2026-05-01

NOT_YET_RECRUITING

Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body RadiotherapyNCT07289646 · 2026-01-15

NOT_YET_RECRUITING

Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen ResponseNCT06822491 · 2024-08-20

ACTIVE_NOT_RECRUITING

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid TumorsNCT05915481 · 2023-06-21

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung CancerNCT05802654 · 2023-06-01

NOT_YET_RECRUITING

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate CancerNCT05430737 · 2022-06-30

Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT SystemNCT06722885 · 2022-01-01

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.NCT05615142 · 2021-12-15

ACTIVE_NOT_RECRUITING

LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRTNCT05919641 · 2020-09-29

Post SBRT Pulmonary Metastasectomy (PSPM) TrialNCT04160143 · 2020-07-14

Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast CancerNCT03750396 · 2018-08-01

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung CancerNCT05802641 · 2018-01-07

Common interventions

SBRTRADIATION3 stereotactic body radiotherapyRADIATION3 CadonilimabDRUG1 Comprehensive Geriatric AssessmentOTHER1 Conventional anatomical planning radiotherapyRADIATION1 Conventional SBRTRADIATION1 Functional Lung avoidance planningRADIATION1 Low Dose RadiotherapyRADIATION1 Neoadjuvant ChemotherapyDRUG1 neoadjuvant immunotherapyDRUG1 Online adaptive SBRTRADIATION1 PD-1 InhibitorsDRUG1 Radiofrequency ablationPROCEDURE1 Standard radiotherapy treatmentRADIATION1 stereotactic body radiation therapyRADIATION1 Stereotactic body radiotherapy (SBRT)RADIATION1 Surgical resectionPROCEDURE1 Surgical resection and stereotactic body radiation therapy (SBRT)PROCEDURE1

Leading sponsors

Peking University Third Hospital3 Gangnam Severance Hospital1 McMaster University1 Odense University Hospital1 Shanghai Pulmonary Hospital, Shanghai, China1 Sichuan University1 Sun Yat-sen University1 Universitair Ziekenhuis Brussel1 University Health Network, Toronto1 University Hospital, Brest1 University of Zurich1 West China Hospital1

Trial status mix

UNKNOWN6

NOT_YET_RECRUITING3

ACTIVE_NOT_RECRUITING2

RECRUITING2

WITHDRAWN1

Phase mix

NA3

PHASE23

PHASE33

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.